Ignite Creation Date:
2025-12-24 @ 4:20 PM
Ignite Modification Date:
2026-01-25 @ 1:18 PM
Study NCT ID:
NCT05537766
Status:
TERMINATED
Last Update Posted:
2025-03-03
First Post:
2022-09-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies
Sponsor:
Kite, A Gilead Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
KT-US-568-0138
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None